The Highest Attainable Standard: Ethical Issues in AIDS Vaccines
- 9 January 1998
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 279 (5348) , 186-188
- https://doi.org/10.1126/science.279.5348.186
Abstract
Developing countries have an urgent need for effective and affordable vaccines to prevent AIDS. Trials of HIV vaccines raise complex ethical as well as scientific issues. Some of the existing international guidelines for biomedical research involving human subjects, as applied to clinical trials of HIV vaccines and other interventions, may be in conflict. In addition, the current ethical guidelines fail to address the concern that poor countries may not find it economically or technically possible to implement some recommendations.Keywords
This publication has 9 references indexed in Scilit:
- The Ethics of Clinical Research in the Third WorldNew England Journal of Medicine, 1997
- The Convention on Human Rights and Biomedicine of the Council of EuropeKennedy Institute of Ethics Journal, 1997
- Antiretroviral Therapy for HIV Infection in 1997JAMA, 1997
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997
- British HIV Association guidelines for antiretroviral treatment of HIV seropositive individualsThe Lancet, 1997
- The European Convention on BioethicsHastings Center Report, 1997
- A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against PertussisNew England Journal of Medicine, 1996
- World Development Report 1993Published by World Bank ,1993